Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.

RL, Gottlieb; CE, Vaca; R, Paredes; J, Mera; BJ, Webb; G, Perez; G, Oguchi; P, Ryan; BU, Nielsen; M, Brown; A, Hidalgo; Y, Sachdeva; S, Mittal; O, Osiyemi; J, Skarbinski; K, Juneja; RH, Hyland; A, Osinusi; S, Chen; G, Camus; M, Abdelghany; S, Davies; N, Behenna-Renton; F, Duff; FM, Marty; MJ, Katz; AA, Ginde; SM, Brown; JT, Schiffer; JA, Hill

doi:10.1056/nejmoa2116846

Public

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.

Shared by NobleBlocks on Dec 22, 2021 • 12:00 AM UTC

Authors:

Gottlieb RL

Vaca CE

Paredes R

Abstract

Background Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with Covid-19 who are at high risk for disease progression prevents hospitalization is uncerta...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!